Sidley is pleased to announce that Chad Ehrenkranz has joined as a partner in the firm’s Healthcare practice in New York and Miami with a particular focus on private equity transactions. Mr. Ehrenkranz joins Sidley from Kirkland & Ellis LLP where he played a key role in the healthcare transactional practice, with a focus on regulatory and enforcement matters, on behalf of private equity sponsors and their portfolio companies.
Mr. Ehrenkranz has built a successful career and track record, regularly representing healthcare clients in structuring and negotiating acquisitions, joint ventures and affiliations, and advising on compliance matters, investigations, employment and consulting arrangements, and other healthcare regulatory issues. In addition, Mr. Ehrenkranz is well-versed in federal and state healthcare regulatory and licensure and regularly advises clients on the corporate practice of medicine, and state and federal fraud and abuse laws.
“We are excited to add a high-caliber Chambers USA-recognized partner to our growing healthcare private equity and M&A practice, which leverages our global and multidisciplinary life sciences and healthcare industry practice,” said Sharon Flanagan, a leader of our Global Life Sciences practice and a member of the firm’s Management Committee and Executive Committee. “Chad has the perfect skill set to team with our M&A and Private Equity partners to support our private equity clients in their increasing investments in the healthcare industry.”
“Chad has led significant healthcare transactional matters, and his addition reflects our continued efforts to substantially grow our global life sciences industry group particularly as it relates to navigating complex healthcare regulatory issues,” said Nancy Chung, member of the firm’s Executive Committee and co-managing partner of Sidley’s New York office. “Chad’s focus on advising healthcare providers is in high demand and will be valued by our clients.”
Sidley’s elite global life sciences practice advises life sciences companies on the full spectrum of their legal needs across the globe. Our globally integrated team of more than 200 lawyers across 12 disciplines represents clients in virtually every sector of the life sciences industry, from traditional pharmaceutical and medical device companies, to healthcare providers and global consumer technology companies engaged in developing new applications for personal health, to innovative financial enterprises investing in dynamic life sciences companies.
Sidley’s preeminent global M&A practice has nearly 500 lawyers that are engaged in the full spectrum of public and private mergers and acquisitions and private equity transactions across a variety of industries including healthcare, energy, life sciences, sports, entertainment, real estate, consumer products, manufacturing, transportation and logistics, technology, media and telecoms, financial services and insurance, and metals and mining.
Sidley is an elite global law firm with nearly US$3 billion in revenue powered by lawyers who practice at the highest level of the profession. Backed by 157 years of experience, we deliver superior service to a high-caliber group of market-leading clients worldwide, while placing a premium on collaboration and diversity.
Source: www.sidley.com
